Test Price
2,800 AED✅ Home Collection Available
GAD1 Gene Cerebral Palsy Type 1, Spastic Quadriplegic Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The GAD1 gene test identifies pathogenic variants causing autosomal recessive spastic quadriplegic cerebral palsy type 1, enabling precise neurological diagnosis and family planning. In the UAE, this NGS-based assay delivers 99.9% diagnostic accuracy for early intervention in high-risk pediatric populations.
| Feature | Our Test (GAD1 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity, detects all variant types | ~95% sensitivity, limited to known point mutations |
| Methodology | NGS (Next-Generation Sequencing) | Sanger Sequencing |
| Speed | 3 to 4 Weeks | 2 to 3 Weeks (limited variant scope) |
Physician Insight & Safety Protocols
As a DHA-licensed Consultant Medical Genetics, I understand that genetic testing for cerebral palsy can be emotionally challenging. This test provides critical clarity for families seeking answers, but always remember that results must be correlated with a full clinical evaluation by a specialist. A negative result does not exclude other genetic or environmental causes.
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
⚠️ Do not discontinue prescribed medication without consulting your doctor
This test does not replace ongoing neurological care. Always consult your specialist before making any changes to medication or treatment plans.
Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or systemic infection may require rescheduling of blood draw.
- Severe anemia or bleeding disorders must be disclosed to the phlebotomist.
- If the patient is under 18, consent must be obtained from a legal guardian in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: If you experience severe bleeding, fainting, or signs of allergic reaction (rash, swelling, difficulty breathing) after sample collection, seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What is the GAD1 gene test and why is it important?
This detects mutations in the GAD1 gene responsible for autosomal recessive spastic quadriplegic cerebral palsy type 1, providing a definitive molecular diagnosis to guide early intervention and genetic counseling.
2. How long does it take to receive results and what do they mean?
Results are available within 3 to 4 weeks; a positive result confirms a pathogenic GAD1 variant, while a negative result significantly reduces the likelihood of this specific genetic form but does not exclude other cerebral palsy causes.
3. What sample is required and is home collection available?
We accept blood, extracted DNA, or a single drop of blood on an FTA card; VIP home collection by a DHA-licensed phlebotomist is available across the UAE from 8 AM to 11 PM, with direct WhatsApp scheduling at +971545488731.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted and handled under strict confidentiality protocols. Clinical procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and informed consent.
Clinical & Logistical Metadata
| Test Name | GAD1 Gene Cerebral Palsy Type 1, Spastic Quadriplegic Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Blood, Extracted DNA, or FTA Card (Dried Blood Spot) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | G82.4 (Spastic quadriplegic cerebral palsy) |
| LOINC Code | 55233-1 (Genetic analysis of a specific gene) |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians